Nucleic Acids Research Advance Access originally published online on December 18, 2006
Nucleic Acids Research 2007 35(Database issue):D823-D828; doi:10.1093/nar/gkl927
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2007, Vol. 35, Database issue D823-D828
© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles |
An enhanced MITOMAP with a global mtDNA mutational phylogeny
1 Center for Molecular and Mitochondrial Medicine and Genetics (MAMMAG) and Departments of Biological Chemistry, Ecology and Evolutionary Biology, and Pediatrics, University of California Irvine, CA 92697-3900, USA 2 Departamento de Bioquimica, Biologia Molecular y Celula, Universidad de Zaragoza Zaragoza, Spain 3 School of Information and Computer Science, University of California Irvine, CA 92697-3425, USA 4 Institute for Genomics and Bioinformatics, University of California Irvine, CA 92697-2025, USA 5 Department of Life Sciences, Building 40 Ben Gurion University, Beer Sheva, Israel
*To whom correspondence should be addressed: Tel: +1 949 824 3490; Fax: +1 949 824 6388; Email: dwallace{at}uci.edu
Received September 14, 2006. Revised October 12, 2006. Accepted October 17, 2006.
 |
ABSTRACT |
|---|
The MITOMAP (http://www.mitomap.org) data system for the human mitochondrial genome has been greatly enhanced by the addition of a navigable mutational mitochondrial DNA (mtDNA) phylogenetic tree of
3000 mtDNA coding region sequences plus expanded pathogenic mutation tables and a nuclear-mtDNA pseudogene (NUMT) data base. The phylogeny reconstructs the entire mutational history of the human mtDNA, thus defining the mtDNA haplogroups and differentiating ancient from recent mtDNA mutations. Pathogenic mutations are classified by both genotype and phenotype, and the NUMT sequences permits detection of spurious inclusion of pseudogene variants during mutation analysis. These additions position MITOMAP for the implementation of our automated mtDNA sequence analysis system, Mitomaster. |
INTRODUCTION |
|---|
MITOMAP is a comprehensive database of human mtDNA variation and its relation to human evolution and disease. The need for a curated and thus reliable database of mitochondrial gene sequence variation with easily used web-based query tools is becoming increasingly essential as the importance of mtDNA variation in the common age-related metabolic and neurodegenerative diseases, aging and cancer is elucidated. The mtDNA encompasses the 13 core polypeptide genes that define the efficiency of the mitochondrial energy generating system oxidative phosphorylation (OXPHOS), the tRNAs and rRNAs for their expression, and a 1121 np control region that regulates mtDNA transcription and replication. The mtDNA also has a unique genetics, being maternally inherited, present in thousands of copies per cell, and capable of encompassing various percentages of mutant and normal molecules (or heteroplasmy) (1). Hence, the mtDNA imparts a quantitative genetics to the vital, systemic function of energy production (1,2).
The 16 569 nt pairs (np) of the closed circular mtDNA are each numbered sequentially and the ‘standard’ base at each position (3) is specified in the ‘revised Cambridge Reference Sequence’ (rCRS), GenBank J01415.2 [GenBank] . This permits any new mtDNA sequence to be unambiguously defined by specifying only the deviant positions and bases relative to the rCRS. Thus, all of the information in MITOMAP can be digitally interrelated.
The human mtDNA has a very high mutation rate, and this has generated three classes of sequence variants: pathogenic, adaptive and neutral. Pathogenic mutations damage conserved gene functions and as the deleterious mutation increases in its percentage heteroplasmy, it erodes systemic cellular energy output. This deficiency is acted on by natural selection and the mutation is soon eliminated from the population as hereditary disease. Hence, all deleterious mutations in the population are relatively recent. Adaptive mtDNA mutations also alter conserved functions but these alterations are advantageous in certain environments. Consequently, they become established in the individual (or homoplasmic) and increase in the population that occupies the compatible environment. Neutral mutations accumulate by chance, but those linked to advantageous mutations can become enriched in particular populations by hitchhiking.
Mutations in the mtDNA not only arise in the female germline, but also accumulate in the post-mitotic cells of the body with age. These somatic mtDNA mutations now appear to be the aging clock and may also be important in the etiology of certain cancers (1,2).
Pathogenic mtDNA mutations can be divided into those that alter more than one gene (inter-gene or contiguous gene defects) and those that affect only one gene (intra-gene or single gene defects). All contiguous gene defects involve rearrangement (insertion-deletion) mutations. Intra-gene mutations include small insertion-deletion mutations or base substitution mutations. The intra-gene mutations can either alter polypeptide coding genes or protein synthesis (rRNA and tRNA) genes. The functional severity of pathogenic nucleotide substitutions can be estimated, in part, through the inter-species conservation index (CI) and for rRNA or tRNA genes by the effect of the base change on the RNA secondary structure. Since the clinical effect of a mutation is the product of both the severity of the mutation and its percentage of heteroplasmy, the clinical phenotypes of heteroplasmic mtDNA mutations can be highly variable among the maternal relatives (1,2). Since mtDNA mutations can arise in both the germline and somatic tissues, they have been associated with both degenerative diseases and cancers (4–6).
Adaptive mutations alter functions and thus are primarily single nucleotide substitution mutations. Moreover, since they are retained in the population by selection, they are frequently ancient and present at polymorphic frequencies. About 25% of the polypeptide amino acid substitution (missense) mutations present in the human mtDNA phylogenetic tree are adaptive (7,8), 10–20% of tRNA mutations appear to be adaptive, as do various rRNA variants (9). Many of these same mutations have also been reported as somatic mutations in cancer cells suggesting that tumors adapt to their changing energetic environment through the evolution of mtDNA variation (10). A surprisingly high proportion of cancer control region somatic mutations are also population polymorphisms (10), suggesting that modulation of mtDNA replication and transcription is an important adaptive strategy.
Since mtDNA mutations accumulate sequentially along maternal mtDNA lineages, the mtDNAs of region-specific branches of the mtDNA tree are founded by a common mtDNA haplotype and thus share a set of common polymorphisms. From this founder, additional mutations are added sequentially over time forming groups of related haplotypes is called a haplogroup. Since selection may have caused the haplogroup to flourish in the new environment, different haplogroups may be functionally different (8,9). Evidence that haplogroups can be functionally different comes from the fact that haplogroups are associated with predilection to or protection from various clinical phenotypes. For instance, haplogroup J increases the risk of developing blindness in association with the milder Leber Hereditary Optic Neuropathy (LHON) mutations (11–13) and haplogroup T increases risk for depression (14). However, other haplogroups are protective against Alzheimer Disease (15–17) and Parkinson Disease (17–19) and are associated with increased longevity (8,20–24).
Throughout the evolution of the symbiosis between the nuclear-cytosol and the mitochondrial organisms, sequences from the mtDNA have been transferred to the nDNA with the result that the vast majority of mitochondrial genes are now located in the nucleus. The transfer of mtDNA sequences to the nDNA continues today, but differences in the mtDNA genetic code that arose prior to the origin of the fungal-animal mtDNA lineage render the mtDNA sequences unintelligible to the nuclear-cytosol system (2). Consequently, all recent mtDNA transfers into the human nDNA have resulted in nuclear-mtDNA pseudogenes (NUMTs) (25). NUMTs are potentially problematic since they can be inadvertently amplified using the polymerase chain reaction (PCR), sequenced, and the pseudogene variants mistaken for pathogenic mtDNA mutations (26,27).
While the mtDNA retains the 13 central OXPHOS proton and electron carries for the OXPHOS circuitry, all of the structural genes necessary to assemble the mitochondrial OXPHOS complexes as well as all of the genes needed to create a mitochondrion are now encoded by the nucleus, a total of 1500 mitochondrial genes. Therefore, many mutations that affect mitochondrial function are the result of nDNA mutations (1,2).
|
A mtDNA SEQUENTIAL MUTATION PHYLOGENETIC TREE |
|---|
A number of factors must be considered when evaluating the nucleotide variants observed in a new mtDNA sequence relative to the rCRS. These include the association between different variants on particular branches of the mtDNA tree (the haplogroup), the time in human mtDNA radiation that the variant appeared and the position of the variant in the protein or RNA gene. All of these considerations were utilized in developing our sequential mutational phylogenetic tree of the human mtDNA.
Our mtDNA tree encompasses the information in 2959 mtDNA coding region sequences, using the rCRS (GenBank J01415.2 [GenBank] ) as the reference. While our tree was assembled primarily using mtDNA coding region single nucleotide polymorphisms (SNPs), informative control region SNPs are also being incorporated when available. However, this dataset is incomplete since the control region sequences have not been reported for many of the published mtDNA sequences used in building the tree. Each sequence was analyzed for possible sequencing errors, identified by base changes inconsistent with the most likely haplogroup. Sequences with multiple potential errors were not included in the dataset. Our tree is now available in MITOMAP, http://www.mitomap.org. Partial representations of the tree are presented in Figure 1.
|
The core topology of the tree was generated by the neighbor-joining program from MEGA (28) using 1060 human mtDNA sequences. The branching order used is highly robust as demonstrated by its consistency within 1000 bootstrap iterations. Separate neighbor-joining trees were also built for each major haplogroup, again with the branching order being robust based in 1000 bootstrap iterations. Then using sequence alignment and sequence comparisons, the positions of the individual nucleotide changes were incorporated into the various branches and nodes of the tree. Since the core tree encompasses all of the major mtDNA haplogroups, new mtDNA sequences can be continually incorporated into the existing tree manually without necessity for further computer analysis. Atypical variants such as insertion-deletions are also added manually and unsolved parallel mutations are resolved by network analysis.
The overall branching order of the human mtDNA tree has been clear for many years (29–32). However, the presence of identical mutations in multiple different parts of the phylogeny was initially puzzling. This was resolved when we concluded that many of these recurrent mutations were due to convergent evolution resulting from adaptive selection acting on specific functional variants (8,9).
The major branches of the tree are labeled with alphabetical letters. The letters were assigned as the mtDNA lineages became apparent. Because Native Americans were found to have a limited number of mtDNA lineages (33), the four major Native American haplogroups were designated A, B, C and D (34,35). Subsequent analysis added haplogroups in Europe (H, I, J, T, U, Uk, V, W and X) (36,37), Asia (many derivatives of macro-haplogroups M and N which radiated out-of-Africa) (38,39) and Africa (haplogroups L0, L1, L2 and L3) (7,40,41). A fifth Native American haplogroup was also found to be related to Eurasian mtDNA haplogroup X (42). The sub-branching order of the haplogroups has been further refined by incorporating subsequent nomenclatural proposals (43) and application of the information derived from complete mtDNA sequences (7,44,45). Since the African mtDNAs lie at the root of the mtDNA phylogeny (29–31), the African haplogroups are presented at the beginning (top) of the phylogenetic tree (Figure 1).
The complete phylogeny with all of the ordered SNPs requires 126 pages to print. To make the tree more accessible, it was integrated and transferred into the Canvas X (ACD Systems, Inc.) program. The PDF file was then exported to http://www.mitomap.org/. In this form, the entire tree can be viewed at any resolution desired, from ultra-low resolution, where all of the branches can be observed but no detail can be perceived, to ultra-high resolution, where the branching order is lost but the individual nucleotide changes can be seen (Figure 1).
The nucleotide position of each change is located in the tree in the order that they arose, and the nature of the mutation, transition versus transversion, given. If the nucleotide change alters a tRNA or an rRNA gene, the mutation is presented in green with the gene designated. If the mutation alters a polypeptide gene, but is synonymous, then it is presented in red with the gene identified. However, if the mutation alters the amino acid sequence of a polypeptide gene, the mutation is presented in black with the affected gene identified and the codon position and amino acid substitution reported. Non-coding variants are shown in blue, and few representative pathogenic mutations are included in the tree in yellow. In this way, all of the common mtDNA sequence changes, their relationship to each other and their potential significance can easily be observed.
Because of how our tree was developed, it is invaluable for analyzing the nature of the nucleotide differences found in any new mtDNA sequence relative to the rCRS. By tracing the nucleotide variants in the new mtDNA sequence along the branching order of our tree, the new sequence's haplogroup is defined, the time that each variant arose (ancient versus recent) is determined and the effect of the sequence variant on the polypeptide or RNA gene revealed.
Ancient functional variants associated with a new sequence may be adaptive variants and may have also arisen independently in other branches of the phylogeny. Many of these have already been identified and discussed (8,9). Variants that do not appear in our phylogenetic tree are likely to be relatively recent mutations. If the mtDNA sequence is from a potentially maternally inherited disease patient and the new mutation is potentially functionally significant, the mutation becomes a candidate for a pathogenic mutation. Neutral variants can be either ancient or recent, but do not alter an important mitochondrial function.
With these rules, a mtDNA sequence from a patient with a potentially maternally inherited disease would be analyzed by first comparing the sequence to the rCRS, and all differences will be listed. These variants would then be used to trace down the various branches of the phylogenetic tree until you arrive at the end of a terminal branch. All sequence variants that have been used thus far are haplogroup-associated polymorphisms. Any variants that are left over must be recent and require additional analysis. If a residual nucleotide change alters an amino acid in a mtDNA polypeptide or the sequence of a tRNA or rRNA, then it is a candidate for a pathogenic mutation. For polypeptide mutations, calculation of the CI of the variant amino acid can give further insight into pathogenicity (8). Similarly, for a tRNA or rRNA sequence change, if the variant alters a conserved nucleotide and/or affects the secondary structure of the RNA then it becomes a candidate for a pathogenic mutation (9). Additional criteria suggesting pathogenicity could include the presence of heteroplasmy and a correlation between the severity of the pathogenic mutation and the percentage of mutant mtDNAs present in various family members along a maternal lineage. Another criterion could be the similarity between the pathological presentation of the mutation and that of a similar type of pathogenic mutation that presents with a similar phenotype.
In certain cases, multiple patients from unrelated families may be found that have closely related mtDNA haplotypes. In these situations, it is possible that the background mtDNA haplogroup is also contributing to the pathogenicity of the deleterious mutation. This type of phenomenon has been documented for the milder pathogenic mutations at nt G11778A, T14484C, and T10663C which cause LHON, which are preferentially associated with mtDNA haplogroups J and T (11–13).
|
PATHOGENIC MTDNA MUTATION TABLES |
|---|
One strong criterion for identifying a pathogenic mtDNA mutation would be if the same mutation had been identified in other patients with similar clinical presentation. To facilitate this type of comparison, the MITOMAP mutational tables have been completely updated and upgraded. The current searchable tables are divided into three major classes: (i) mutations associated with LHON, (ii) mutations that affect polypeptide sequences but present with other phenotypes and (iii) mutations that alter tRNAs and rRNAs and present with a various multi-system clinical problems. These tables and the associated clinical diseases are explained in depth in our various clinical reviews (2,46,47). As an example, the LHON disease mutations have been sub-classified into two main categories. The first category includes well characterized and causative mutations designated the ‘top 10’ primary LHON mutations. This group includes the three most common LHON mutations (G3460A, G11778A and T14484C) with account for
95% of LHON patients. The second mutation category includes mutations that have been reported in a single family and thus require additional independent reports to confirm their causal association with LHON. If in the process of analyzing an mtDNA sequence from a patient, one of the recent sequence differences is also present in one of the pathogenic mutational tables, then this mutation becomes a good likely candidate for the disease mutation. However, it must be remembered that the mtDNA haplogroup background can be a contributing factor in some diseases such as LHON. Hence, it is important that the role of the mutation be considered in the larger context of what we know about human mitochondrial genetics (2).
|
MITOCHONDRIAL DISEASES OF NUCLEAR GENETIC ORIGIN |
|---|
While the mtDNA encodes 37 critical genes for OXPHOS (13 polypeptides, 22 tRNAs and 2 rRNAs) the nDNA encodes in the order of 1500 additional mitochondrial proteins and mutations in these genes can also cause mitochondrial disease. Hence, many of the more severe mitochondrial diseases can be caused by mutations in nDNA encoded genes for the structural or assembly proteins of the OXPHOS complexes and a spectrum of disorders can result from nDNA mutations that affect mtDNA replication (48). To alert MITOMAP users to these important classes of mitochondrial disease, MITOMAP now includes summary tables of the known nDNA-encoded mitochondrial diseases (2).
|
NUMT PSEUDOGENE DATABASE |
|---|
The nDNA also encodes 247 fragments of the mtDNA of sufficiently recent origin to be easily mistaken for legitimate mtDNA sequences. Inadvertent PCR amplification of one of these sequences during a clinical study can result in the erroneous conclusion that the sequence variants within the NUMT pseudogene are the cause of the disease (26,27).
To address this problem, we have developed a MITOMAP human NUMT database (25). By scanning the NUMT sequences that encompass the same region as that of clinical interest, the potential nDNA pseudogene variants can be identified.
|
REFERENCE DATABASE |
|---|
The MITOMAP database currently encompasses over 5100 references. These pertain to the mtDNA sequence, sequence variation and mitochondrial role in a wide variety of diseases. This reference database is searchable by author and subject word.
|
MITOMAP COMPUTATIONAL SYSTEM AND DATABASE MAINTENANCE |
|---|
 TOPABSTRACTINTRODUCTIONA mtDNA SEQUENTIAL MUTATION...PATHOGENIC MTDNA MUTATION TABLESMITOCHONDRIAL DISEASES OF...NUMT PSEUDOGENE DATABASEREFERENCE DATABASE MITOMAP COMPUTATIONAL SYSTEM AND... DISCUSSIONREFERENCES |
|---|
All of the data for MITOMAP is now managed in PostgreSQL (http://www.postgresql.org/), an open-source database management system (i.e. DBMS) with object-relational modeling capabilities. All programs are written in the Perl programming language.
Data for MITOMAP are initially extracted by the database curators and stored, formatted and screened in Excel spreadsheets. Updated versions of the curated data are then periodically uploaded to the server, where Perl programs implementing the ParseExcel and DBI modules are used to parse the values from the spreadsheets and populate the data structures implemented in PostgreSQL. Error screening is performed both by the curator and by the population programs.
The MITOMAP servers are located at the University of California, Irvine, on a dual-processor server running RedHat Linux as its operating system. This system is accessed through a dynamic web interface using an Apache webserver.
|
DISCUSSION |
|---|
By adding the mtDNA mutational tree, updating the depth and breadth of the mtDNA disease mutation tables and creating a NUMT pseudogene sequence database, we have now generated the informational infrastructure that will permit MITOMAP to evolve from a simple factual database to an intelligent analytical system. The sequential mutation mtDNA phylogenetic tree places all of the factual information about mtDNA sequence variation into an evolutionary and functional context. This single integrated entity thus automatically sorts mtDNA variants into ancient versus recent mutations, defines the gene affected and provides preliminary information on the potential functional implications of the mutation.
From this foundation, MITOMAP is now poised to implement our much more powerful data integration and analysis system, MITOMASTER. The MITOMAP-MITOMASTER system will permit the user to up-load a new mtDNA sequence, and the system will automatically identify the sequence variants relative to the rCRS, determine the mtDNA haplogroup, indicate the potentially functional variants, check for NUMT pseudogene variants and provide a list of potential disease causing mutations. Hence MITOMAP-MITOMASTER will soon be an important bioinformatics tool in the analysis of human mtDNA sequence variation.
|
ACKNOWLEDGEMENTS |
|---|
This research has been supported by NIH grants NS213L8, HL64017, AG13154 and an Ellison Foundation Senior Investigator Grant awarded to Douglas C. Wallace; NIH Biomedical Informatics Training Grant T15 LM007443, NSF grant EIA-0321390 and a UCI Laurel Wilknening Faculty Innovation Award to Pierre Baldi; and Spanish Fondo de Investigacion Sanitaria grant # PI050647, Diputacion General de Aragon Grupos consolidados B33 and by Ciber Enfermedades raras (CB06/07/0043). Funding to pay the Open Access publication charges for this article was provided by AG24373.
Conflict of interest statement. None declared.
|
REFERENCES |
|---|
- Wallace, D.C. (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine Annu. Rev. Genet, . 39, 359–407[CrossRef][Web of Science][Medline] .
- Wallace, D.C., Lott, M.T., Procaccio, V. Mitochondrial genes in degenerative diseases, cancer and aging (Chapter 13). In Rimoin, D.L., Connor, J.M., Pyeritz, R.E., Korf, B.R. (Eds.). Emery and Rimoin's Principles and Practice of Medical Genetics, 5th Edition London Churchill Livingstone pp. 194–298 .
- Anderson, S., Bankier, A.T., Barrell, B.G., de Bruijn, M.H., Coulson, A.R., Drouin, J., Eperon, I.C., Nierlich, D.P., Roe, B.A., Sanger, F., et al. (1981) Sequence and organization of the human mitochondrial genome Nature, 290, 457–465[CrossRef][Medline] .
- Petros, J.A., Baumann, A.K., Ruiz-Pesini, E., Amin, M.B., Sun, C.Q., Hall, J., Lim, S., Issa, M.M., Flanders, W.D., Hosseini, S.H., et al. (2005) mtDNA mutations increase tumorigenicity in prostate cancer Proc. Natl Acad. Sci. USA, 102, 719–724
[Abstract/Free Full Text] . - Wallace, D.C. (2005) Mitochondria and Cancer: Warburg Address Cold Spring Harb. Symp. Quant. Biol, . 70, 363–374[CrossRef][Medline] .
- Brandon, M., Baldi, P., Wallace, D.C. (2006) Mitochondrial mutations in cancer Oncogene, 25, 4647–4662[CrossRef][Web of Science][Medline] .
- Mishmar, D., Ruiz-Pesini, E.E., Golik, P., Macaulay, V., Clark, A.G., Hosseini, S., Brandon, M., Easley, K., Chen, E., Brown, M.D., et al. (2003) Natural selection shaped regional mtDNA variation in humans Proc. Natl Acad. Sci. USA, 100, 171–176
[Abstract/Free Full Text] . - Ruiz-Pesini, E., Mishmar, D., Brandon, M., Procaccio, V., Wallace, D.C. (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA Science, 303, 223–226
[Abstract/Free Full Text] . - Ruiz-Pesini, E. and Wallace, D.C. (2006) Evidence for adaptive selection acting on the tRNA and rRNA genes of the human mitochondrial DNA Hum. Mutat, . 27, 1072–1081[CrossRef][Web of Science][Medline] .
- Brandon, M.C., Baldi, P., Wallace, D.C. (2006) Mitochondrial mutations in cancer Oncogene, 25, 4647–4662[CrossRef][Web of Science][Medline] .
- Brown, M.D., Starikovskaya, E., Derbeneva, O., Hosseini, S., Allen, J.C., Mikhailovskaya, I.E., Sukernik, R.I., Wallace, D.C. (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum. Genet, . 110, 130–138 .
- Brown, M.D., Sun, F., Wallace, D.C. (1997) Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage Am. J. Hum. Genet, . 60, 381–387[Web of Science][Medline] .
- Torroni, A., Petrozzi, M., D'Urbano, L., Sellitto, D., Zeviani, M., Carrara, F., Carducci, C., Leuzzi, V., Carelli, V., Barboni, P., et al. (1997) Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484 Am. J. Hum. Genet, . 60, 1107–11021[Web of Science][Medline] .
- McMahon, F.J., Chen, Y.S., Patel, S., Kokoszka, J., Brown, M.D., Torroni, A., DePaulo, J.R., Wallace, D.C. (2000) Mitochondrial DNA sequence diversity in bipolar affective disorder Am. J. Psychiatry, 157, 1058–1064
[Abstract/Free Full Text] . - Chagnon, P., Gee, M., Filion, M., Robitaille, Y., Belouchi, M., Gauvreau, D. (1999) Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population Am. J. Med. Genet, . 85, 20–30[CrossRef][Web of Science][Medline] .
- Carrieri, G., Bonafe, M., De Luca, M., Rose, G., Varcasia, O., Bruni, A., Maletta, R., Nacmias, B., Sorbi, S., Corsonello, F., et al. (2001) Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease Hum. Genet, . 108, 194–198[CrossRef][Web of Science][Medline] .
- van der Walt, J.M., Dementieva, Y.A., Martin, E.R., Scott, W.K., Nicodemus, K.K., Kroner, C.C., Welsh-Bohmer, K.A., Saunders, A.M., Roses, A.D., Small, G.W., et al. (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk Neurosci. Lett, . 365, 28–32[CrossRef][Web of Science][Medline] .
- van der Walt, J.M., Nicodemus, K.K, Martin, E.R., Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Haines, J.L., Koller, W.C., Lyons, K., et al. (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson Disease Am. J. Hum. Genet, . 72, 804–811[CrossRef][Web of Science][Medline] .
- Ghezzi, D., Marelli, C., Achilli, A., Goldwurm, S., Pezzoli, G., Barone, P., Pellecchia, M.T., Stanzione, P., Brusa, L., Bentivoglio, A.R., et al. (2005) Mitochondrial DNA haplogroup K is associated with a lower risk of parkinson's disease in Italians Eur. J. Hum. Genet, . 13, 748–752[CrossRef][Web of Science][Medline] .
- De Benedictis, G., Rose, G., Carrieri, G., De Luca, M., Falcone, E., Passarino, G., Bonafe, M., Monti, D., Baggio, G., Bertolini, S., et al. (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans FASEB J, . 13, 1532–1536
[Abstract/Free Full Text] . - Coskun, P.E., Ruiz-Pesini, E.E., Wallace, D.C. (2003) Control region mtDNA variants: longevity, climatic adaptation and a forensic conundrum Proc. Natl Acad. Sci. USA, 100, 2174–2176
[Free Full Text] . - Ivanova, R., Astrinidis, A., Lepage, V., Kouvatsi, A., Djoulah, S., Hors, J., Charron, D. (1999) Mitochondrial DNA polymorphism in the French population Biomed. Pharmacother, . 53, 207–212[CrossRef][Medline] .
- Ross, O.A., McCormack, R., Curran, M.D., Duguid, R.A., Barnett, Y.A., Rea, I.M., Middleton, D. (2001) Mitochondrial DNA polymorphism: its role in longevity of the Irish population Exp. Gerontol, . 36, 1161–1178[CrossRef][Web of Science][Medline] .
- Niemi, A.K., Hervonen, A., Hurme, M., Karhunen, P.J., Jylha, M., Majamaa, K. (2003) Mitochondrial DNA polymorphisms associated with longevity in a Finnish population Hum. Genet, . 112, 29–33[CrossRef][Web of Science][Medline] .
- Mishmar, D., Ruiz-Pesini, E., Brandon, M., Wallace, D.C. (2004) Mitochondrial DNA-like sequences in the nucleus (NUMTs): insights into our African origins and the mechanism of foreign DNA integration Hum. Mutat, . 23, 125–133[CrossRef][Web of Science][Medline] .
- Davis, R.E., Miller, S., Herrnstadt, C., Ghosh, S.S., Fahy, E., Shinobu, L.A., Galasko, D., Thal, L.J., Beal, M.F., Howell, N., et al. (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease Proc. Natl Acad. Sci. USA, 94, 4526–4531
[Abstract/Free Full Text] . - Wallace, D.C., Stugard, C., Murdock, D., Schurr, T., Brown, M.D. (1997) Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations Proc. Natl Acad. Sci. USA, 94, 14900–14905
[Abstract/Free Full Text] . - Kumar, S., Tamura, K., Jakobsen, I.B., Nei, M. (2001) MEGA2: molecular evolutionary genetics analysis software Bioinformatics, 17, 1244–1245
[Abstract/Free Full Text] . - Johnson, M.J., Wallace, D.C., Ferris, S.D., Rattazzi, M.C., Cavalli-Sforza, L.L. (1983) Radiation of human mitochondria DNA types analyzed by restriction endonuclease cleavage patterns J. Mol. Evol, . 19, 255–271[CrossRef][Web of Science][Medline] .
- Cann, R.L., Stoneking, M., Wilson, A.C. (1987) Mitochondrial DNA and human evolution Nature, 325, 31–36[CrossRef] .
- Merriwether, D.A., Clark, A.G., Ballinger, S.W., Schurr, T.G., Soodyall, H., Jenkins, T., Sherry, S.T., Wallace, D.C. (1991) The structure of human mitochondrial DNA variation J. Mol. Evol, . 33, 543–555[CrossRef][Web of Science][Medline] .
- Wallace, D.C. (1995) 1994 William Allan Award Address. Mitochondrial DNA variation in human evolution, degenerative disease, and aging Am. J. Hum. Genet, . 57, 201–223[Web of Science][Medline] .
- Wallace, D.C., Garrison, K., Knowler, W.C. (1985) Dramatic founder effects in Amerindian mitochondrial DNAs Am. J. Phys. Anthropol, . 68, 149–155[CrossRef][Web of Science][Medline] .
- Schurr, T.G., Ballinger, S.W., Gan, Y.Y., Hodge, J.A., Merriwether, D.A., Lawrence, D.N., Knowler, W.C., Weiss, K.M., Wallace, D.C. (1990) Amerindian mitochondrial DNAs have rare Asian mutations at high frequencies, suggesting they derived from four primary maternal lineages Am. J. Hum. Genet, . 46, 613–623[Web of Science][Medline] .
- Torroni, A., Schurr, T.G., Yang, C.C., Szathmary, E.J., Williams, R.C., Schanfield, M.S., Troup, G.A., Knowler, W.C., Lawrence, D.N., Weiss, K.M., et al. (1992) Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations Genetics, 130, 153–162[Abstract] .
- Torroni, A., Lott, M.T., Cabell, M.F., Chen, Y., Laverge, L., Wallace, D.C. (1994) MtDNA and the origin of Caucasians. identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region Am. J. Hum. Genet, . 55, 760–776[Web of Science][Medline] .
- Torroni, A., Huoponen, K., Francalacci, P., Petrozzi, M., Morelli, L., Scozzari, R., Obinu, D., Savontaus, M.L., Wallace, D.C. (1996) Classification of European mtDNAs from an analysis of three European populations Genetics, 144, 1835–1850[Abstract] .
- Ballinger, S.W., Schurr, T.G., Torroni, A., Gan, Y.Y., Hodge, J.A., Hassan, K., Chen, K.H., Wallace, D.C. (1992) Southeast Asian mitochondrial DNA analysis reveals genetic continuity of ancient mongoloid migrations [published erratum appears in Genetics 1992 Apr;130(4):957] Genetics, 130, 139–152[Abstract] .
- Torroni, A., Miller, J.A., Moore, L.G., Zamudio, S., Zhuang, J., Droma, R., Wallace, D.C. (1994) Mitochondrial DNA analysis in Tibet implications for the origin of the Tibetan population and its adaptation to high altitude Am. J. Phys. Anthropol, . 93, 189–199[CrossRef][Web of Science][Medline] .
- Chen, Y.S., Torroni, A., Excoffier, L., Santachiara-Benerecetti, A.S., Wallace, D.C. (1995) Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups Am. J. Hum. Genet, . 57, 133–149[Web of Science][Medline] .
- Chen, Y.S., Olckers, A., Schurr, T.G., Kogelnik, A.M., Huoponen, K., Wallace, D.C. (2000) mtDNA variation in the South African Kung and Khwe and their genetic relationships to other African populations Am. J. Hum. Genet, . 66, 1362–1383[CrossRef][Web of Science][Medline] .
- Brown, M.D., Hosseini, S.H., Torroni, A., Bandelt, H.J., Allen, J.C., Schurr, T.G., Scozzari, R., Cruciani, F., Wallace, D.C. (1998) mtDNA Haplogroup X: an ancient link between Europe/Western Asia and North America? Am. J. Hum. Genet, . 63, 1852–1861[CrossRef][Web of Science][Medline] .
- Macaulay, V., Richards, M., Hickey, E., Vega, E., Cruciani, F., Guida, V., Scozzari, R., Bonne-Tamir, B., Sykes, B., Torroni, A. (1999) The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs Am. J. Hum. Genet, . 64, 232–249[CrossRef][Web of Science][Medline] .
- Wallace, D.C., Brown, M.D., Schurr, T.G., Chen, E., Chen, Y.-S., Starikovskaya, Y.B., Sukernik, R.I. (2000) Global mitochordrial DNA variation and the origin of Native Americans The Origin of Humankind. Conference Proceedings of the International Symposium, 14–15 May 1998, VeniceIn Aloisi, M., Battaglia, B., Carafoli, E., Danieli, G.A. (Eds.). Venice IOS Press pp. 9–11 .
- Ingman, M., Kaessmann, H., Paabo, S., Gyllensten, U. (2000) Mitochondrial genome variation and the origin of modern humans Nature, 408, 708–713[CrossRef][Medline] .
- Wallace, D.C. and Lott, M.T. (2002) Mitochondrial genes in degenerative diseases, cancer and aging In Rimoin, D.L., Connor, J.M., Pyeritz, R.E., Korf, B.R. (Eds.). Emery and Rimoin's Principles and Practice of Medical Genetics, Fourth ed London Churchill Livingstone pp. 299–409 .
- Wallace, D.C., Lott, M.T., Brown, M.D., Kerstann, K. (2001) Mitochondria and Neuro-opthalmological disease In Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.). The Metabolic and Molecular Basis of Inherited Disease, Eighth ed New York McGraw-Hill Vol. II, pp. 2425–2512 .
- Rubio-Gozalbo, M.E., Dijkman, K.P., van den Heuvel, L.P., Sengers, R.C., Wendel, U., Smeitink, J.A. (2000) Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations Hum. Mutat, . 15, 522–532[CrossRef][Web of Science][Medline]
.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. D'Aurelio, C. Vives-Bauza, M.M. Davidson, and G. Manfredi Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells Hum. Mol. Genet., November 12, 2009; (2009) ddp503v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Wong, S. Rajagopalan, S. M. Freund, T. J. Rutherford, A. Andreeva, F. M. Townsley, M. Petrovich, and A. R. Fersht Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53 Nucleic Acids Res., November 1, 2009; 37(20): 6765 - 6783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Balloux, L.-J. L. Handley, T. Jombart, H. Liu, and A. Manica Climate shaped the worldwide distribution of human mitochondrial DNA sequence variation Proc R Soc B, October 7, 2009; 276(1672): 3447 - 3455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Brandon, D. C. Wallace, and P. Baldi Data structures and compression algorithms for genomic sequence data Bioinformatics, July 15, 2009; 25(14): 1731 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Byung Chan Lim, Jun Dong Park, H. Hwang, Ki Joong Kim, Yong Seung Hwang, J.-H. Chae, J.-E. Cheon, In One Kim, R. Lee, and Han Ku Moon Mutations in ND Subunits of Complex I Are an Important Genetic Cause of Childhood Mitochondrial Encephalopathies J Child Neurol, July 1, 2009; 24(7): 828 - 832. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Zhidkov, E. A. Livneh, E. Rubin, and D. Mishmar mtDNA mutation pattern in tumors and human evolution are shaped by similar selective constraints Genome Res., April 1, 2009; 19(4): 576 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fukui and C. T. Moraes Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons Hum. Mol. Genet., March 15, 2009; 18(6): 1028 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Blakely, S. A. Trip, H. Swalwell, L. He, D. R. Wren, P. Rich, D. M. Turnbull, S. E. Omer, and R. W. Taylor A New Mitochondrial Transfer RNAPro Gene Mutation Associated With Myoclonic Epilepsy With Ragged-Red Fibers and Other Neurological Features Arch Neurol, March 1, 2009; 66(3): 399 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Camilleri, P. Carlson, A. R. Zinsmeister, S. McKinzie, I. Busciglio, D. Burton, E. A. Zaki, and R. G. Boles Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G510 - G516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. O'Brien, Y. Zhang, E. Wang, V. Marie, W. Badejoko, B. F. Lang, and G. Burger GOBASE: an organelle genome database Nucleic Acids Res., January 1, 2009; 37(suppl_1): D946 - D950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Seibel, C. Di Nunno, C. Kukat, I. Schafer, R. Del Bo, A. Bordoni, G. P. Comi, A. Schon, F. Capuano, D. Latorre, et al. Cosegregation of novel mitochondrial 16S rRNA gene mutations with the age-associated T414G variant in human cybrids Nucleic Acids Res., October 1, 2008; 36(18): 5872 - 5881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Malyarchuk, T. Grzybowski, M. Derenko, M. Perkova, T. Vanecek, J. Lazur, P. Gomolcak, and I. Tsybovsky Mitochondrial DNA Phylogeny in Eastern and Western Slavs Mol. Biol. Evol., August 1, 2008; 25(8): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ingman and U. Gyllensten Rate variation between mitochondrial domains and adaptive evolution in humans Hum. Mol. Genet., October 1, 2007; 16(19): 2281 - 2287. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||